Occupational asthma due to 5-aminosalicylic acid

Occupational and Environmental Medicine

Volumn 67, Issue 11, 2010, Pages 798-799

  Sastre, Joaquín ^a,b   García Del Potro, Manuela ^a   Aguado, Erika ^a   Fernández Nieto, Mar ^a,b  

^a Hospital UniversitarioFundación Jiménez Díaz   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

MESALAZINE; SALBUTAMOL;

ADULT; CASE REPORT; COUGHING; DRUG INDUSTRY; DYSPNEA; HUMAN; LETTER; MALE; OCCUPATIONAL ASTHMA; PRICK TEST; PRIORITY JOURNAL; PROVOCATION TEST; WHEEZING;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASTHMA; DRUG INDUSTRY; HUMANS; MALE; MESALAMINE; MIDDLE AGED; OCCUPATIONAL DISEASES;

EID: 78149412525     PISSN: 13510711     EISSN: 14707926     Source Type: Journal    
DOI: 10.1136/oem.2010.058008     Document Type: Letter

References (4)

1. Ransford RAJ, Langmen MJS. Sulphasalazine and mesalazine: serious adverse reactions re-evaluated on the basis of suspected adverse reaction reports to the Committee on Safety of Medicines. Gut 2002;51:536-9.
2. Baker DE, Kane S. The short- and long-term safety of 5-aminosalicylate products in the treatment of ulcerative colitis. Rev Gastroenterol Disord 2004;4:86-91. (Pubitemid 38811489)
3. Vázquez Fuertes L, Martínez-Cócera C, Robledo Echarren T, et al. Induction of tolerance in hypersensitivity to mesalazine (5-ASA). An Med Interna 2005;22:586-8.
4. Fernández-Nieto M, Sastre B, Sastre J, et al. Changes in sputum eicosanoids and inflammatory markers after inhalation challenges with occupational agents. Chest 2009;136:1308-15.